The effects of antidepressants on methylation of the SLC6a2 gene could be tested more thoroughly using cell-based systems, animal models or post-mortem human tissues, comparing tissues from subjects with and without MDD, and with or without antidepressant treatment. This evidence concerns the gene SLC6A2 and major depressive disorder.